Inventor
ANDERSEN KIM VILBOUR
DK48 patents
⚠️ This page may combine multiple inventors who share the name “ANDERSEN KIM VILBOUR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MAXYGEN HOLDINGS LTD
17 patentsUS6555660B2Apr 29, 2003
G-CSF conjugates
MAXYGEN HOLDINGS LTD149 citations97
US6646110B2Nov 11, 2003
G-CSF polypeptides and conjugates
MAXYGEN HOLDINGS LTD161 citations96
US7442524B2Oct 28, 2008
Factor VII or VIIa-like molecules
MAXYGEN HOLDINGS LTD10 citations92
US7427592B2Sep 23, 2008
Factor VII or VIIa - like molecules
MAXYGEN HOLDINGS LTD10 citations92
US7414022B2Aug 19, 2008
Factor VII or VIIa-like molecules
MAXYGEN HOLDINGS LTD12 citations92
US7371543B2May 13, 2008
Factor VII or VIIa-like molecules
MAXYGEN HOLDINGS LTD15 citations92
US7230081B1Jun 12, 2007
Interferon gamma conjugates
MAXYGEN HOLDINGS LTD47 citations91
US6831158B2Dec 14, 2004
G-CSF conjugates
MAXYGEN HOLDINGS LTD38 citations91
US7504237B2Mar 17, 2009
Polynucleotides encoding interferon gamma polypeptides
MAXYGEN HOLDINGS LTD10 citations82
US7524931B2Apr 28, 2009
Full-length interferon gamma polypeptide variants
MAXYGEN HOLDINGS LTD9 citations75
US7226999B2Jun 5, 2007
Protein C or activated protein C-like molecules
MAXYGEN HOLDINGS LTD5 citations72
US6933367B2Aug 23, 2005
Protein C or activated protein C-like molecules
MAXYGEN HOLDINGS LTD10 citations72
US7550565B2Jun 23, 2009
G-CSF conjugates
MAXYGEN HOLDINGS LTD3 citations61
US6958388B2Oct 25, 2005
Interferon gamma polypeptide variants
MAXYGEN HOLDINGS LTD4 citations57
US7550566B2Jun 23, 2009
G-CSF conjugates
MAXYGEN HOLDINGS LTD0 citations51
US7232562B2Jun 19, 2007
E38N interferon gamma polypeptide variants
MAXYGEN HOLDINGS LTD0 citations51
US7390638B2Jun 24, 2008
S99T C-11 Truncated polynucleotides encoding interferon gamma polypeptide variants
MAXYGEN HOLDINGS LTD0 citations47
NOVOZYMES AS
9 patentsUS6939702B1Sep 6, 2005
Lipase variant
NOVOZYMES AS372 citations98
US6780629B2Aug 24, 2004
Subtilase enzymes
NOVOZYMES AS20 citations92
US6555355B1Apr 29, 2003
Protease variants and compositions
NOVOZYMES AS30 citations92
US7993898B2Aug 9, 2011
Cellulase variants
NOVOZYMES AS16 citations91
US6461849B1Oct 8, 2002
Modified polypeptide
NOVOZYMES AS32 citations91
US7288401B2Oct 30, 2007
Protease variants and compositions
NOVOZYMES AS12 citations84
US6558938B1May 6, 2003
Protease variants and compositions
NOVOZYMES AS14 citations84
US8017372B2Sep 13, 2011
Cellulase variants
NOVOZYMES AS14 citations82
US6921657B2Jul 26, 2005
Protease variants and compositions
NOVOZYMES AS10 citations73
BAYER HEALTHCARE LLC
6 patentsUS7511024B2Mar 31, 2009
Factor VII or VIIA-like molecules
BAYER HEALTHCARE LLC28 citations96
US7700733B2Apr 20, 2010
Factor VII or VIIa polypeptide variants
BAYER HEALTHCARE LLC14 citations82
US7517974B2Apr 14, 2009
Factor VII or VIIa-like molecules
BAYER HEALTHCARE LLC3 citations74
US7771996B2Aug 10, 2010
FVII or FVIIa variants
BAYER HEALTHCARE LLC6 citations67
US7754682B2Jul 13, 2010
Factor VII or VIIa—like molecules
BAYER HEALTHCARE LLC0 citations52
US7807638B2Oct 5, 2010
Factor V11 or factor V11A GLA domain variants
BAYER HEALTHCARE LLC1 citations50
MAXYGEN APS
5 patentsUS6806063B2Oct 19, 2004
Factor VII or VIIa-like molecules
MAXYGEN APS184 citations98
US7338788B2Mar 4, 2008
Interferon-β variants and conjugates
MAXYGEN APS42 citations95
US6531122B1Mar 11, 2003
Interferon-β variants and conjugates
MAXYGEN APS91 citations95
US7144574B2Dec 5, 2006
Interferon β variants and conjugates
MAXYGEN APS35 citations91
US7431921B2Oct 7, 2008
Interferon beta-like molecules
MAXYGEN APS7 citations72